Insider Trading & Ownership - Mahoney Stephen F.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Mahoney Stephen F.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-09-16
Sale
2021-09-20
5:02 pm
Magenta Therapeutics Inc.MGTAMahoney Stephen F.
See Remarks
5,736$6.73$38,60314,264
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-10-30
Option Award
2023-11-01
4:35 pm
N/A
2033-10-30
Viridian Therapeutics Inc.VRDNMahoney Stephen F.
President and CEO
1,259,400$01,259,400
(Direct)
View
2022-11-30
Option Award
2022-12-02
4:23 pm
N/A
N/A
Magenta Therapeutics Inc.MGTAMahoney Stephen F.
See Remarks
3,000$0.9417,264
(Direct)
View
2022-08-01
Option Award
2022-08-01
9:11 pm
N/A
2032-07-31
Magenta Therapeutics Inc.MGTAMahoney Stephen F.
See Remarks
130,000$0130,000
(Direct)
View
2022-05-17
Option Award
2022-05-19
4:19 pm
N/A
2032-05-16
Magenta Therapeutics Inc.MGTAMahoney Stephen F.
See Remarks
62,500$062,500
(Direct)
View
2022-02-15
Option Award
2022-02-17
5:16 pm
N/A
2032-02-14
Magenta Therapeutics Inc.MGTAMahoney Stephen F.
See Remarks
130,000$0130,000
(Direct)
View
2021-09-14
Option Award
2021-09-16
7:41 pm
N/A
N/A
Magenta Therapeutics Inc.MGTAMahoney Stephen F.
See Remarks
20,000$020,000
(Direct)
View
2020-11-02
Option Award
2020-11-04
4:39 pm
N/A
2030-11-01
Magenta Therapeutics Inc.MGTAMahoney Stephen F.
See Remarks
435,000$0435,000
(Direct)
View
2019-09-17
Option Award
2019-09-19
4:18 pm
N/A
2029-09-16
Kiniksa Pharmaceuticals Ltd.KNSAMahoney Stephen F.
President & COO
82,000$082,000
(Direct)
View